Literature DB >> 10821808

Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase.

T C Lee1, Y D Zhao, D W Courtman, D J Stewart.   

Abstract

BACKGROUND: Endothelium-derived nitric oxide (NO) is produced by an oxidative reaction catalyzed by endothelial NO synthase (eNOS). NO plays a crucial role in controlling cell growth and apoptosis, as well as having well-characterized vasodilator and antithrombotic actions. More recently, endothelium-derived NO was shown to be involved in postdevelopmental vascular remodeling and angiogenesis, as well as in the formation of limb vasculature during embryogenesis. Therefore, we investigated the role of endothelium-derived NO during cardiovascular development using mice deficient in eNOS. METHODS AND
RESULTS: We examined the hearts of 12 mature eNOS-deficient and 26 mature wild-type mice. Five of the mature eNOS-deficient mice had a bicuspid aortic valve; none of the 26 wild-type animals exhibited identifiable valvular or cardiac abnormalities. Immunohistochemical analysis revealed prominent eNOS expression localized to the endothelium lining the valve cusps of the aorta in mature wild-type mice; expression was localized to the myocardium and endothelial cell monolayer lining the valve leaflets in the developing embryo.
CONCLUSIONS: These results show a strong association between eNOS deficiency and the presence of a bicuspid aortic valve; they provide the first molecular insight into one of the most common types of congenital cardiac abnormality.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821808     DOI: 10.1161/01.cir.101.20.2345

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  109 in total

1.  Loss of Gata5 in mice leads to bicuspid aortic valve.

Authors:  Brigitte Laforest; Gregor Andelfinger; Mona Nemer
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 2.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling.

Authors:  Joyce A Schroeder; Leslie F Jackson; David C Lee; Todd D Camenisch
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

3.  Bicuspid aortic valve and coarctation: two villains part of a diffuse problem.

Authors:  C A Warnes
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

4.  Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells.

Authors:  Shinichi Kanno; Peter K M Kim; Karim Sallam; Jing Lei; Timothy R Billiar; Larry L Shears
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

5.  Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling.

Authors:  Bo Shen; Lin Gao; Yi-Te Hsu; Grant Bledsoe; Makato Hagiwara; Lee Chao; Julie Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

6.  Asymmetric Dimethylarginine in Patients with Ascending Aortic Aneurysms.

Authors:  Natalia D Gavriliuk; Tatiana A Druzhkova; Olga B Irtyuga; Alexandr A Zhloba; Tatiana F Subbotina; Vladimir E Uspenskiy; Nina P Alexeyeva; Olga M Moiseeva
Journal:  Aorta (Stamford)       Date:  2016-12-01

Review 7.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling.

Authors:  Shuai Yuan; Christopher G Kevil
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

Review 8.  A measured approach to managing the aortic root in patients with bicuspid aortic valve disease.

Authors:  Ismail El-Hamamsy; Magdi H Yacoub
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

9.  Approach to the patient with bicuspid aortic valve and ascending aorta aneurysm.

Authors:  José T Ortiz; David D Shin; Nalini M Rajamannan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

10.  Growth and maturation of heart valves leads to changes in endothelial cell distribution, impaired function, decreased metabolism and reduced cell proliferation.

Authors:  Lindsey J Anstine; Chris Bobba; Samir Ghadiali; Joy Lincoln
Journal:  J Mol Cell Cardiol       Date:  2016-10-15       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.